Abstract
Vincristine is an antimitotic agent used for treatment of leukemia, lymphomas, and cancers. Its main side effect is a dose-related, length-dependent (LD) axonal neuropathy. We performed electrodiagnostic (EDx) examinations in 17 children who had been treated with vincristine and who presented with the clinical picture of a peripheral neuropathy. The mean dose of vincristine was 8.5 ± 4.0 mg/m(2) . Clinical motor symptoms were more frequent and more severe than sensory ones. Thirteen children presented with a motor deficit, 4 of whom could no longer walk. EDx examination showed an axonal neuropathy with a non-length-dependent (NLD) pattern in 9 children and an LD pattern in 8. A major motor predominance was encountered in 12 patients. The electrophysiological and clinical motor predominance described differs from the mainly sensory neuropathy reported in adults. Incomplete myelination due to young age may have resulted in greater sensitivity of some nerves to neurotoxic agents. Muscle Nerve, 2015.
References
Sep 1, 1975·Neurology·L P Levitt, D Prager
Feb 25, 1976·Cell and Tissue Research·D R Tomlinson, T Bennett
Aug 1, 1969·Journal of Neurology, Neurosurgery, and Psychiatry·J G McLeod, R Penny
Feb 1, 1970·Journal of the Neurological Sciences·W G BradleyJ N Walton
Apr 1, 1969·Neurology·S G SandlerE S Henderson
Oct 13, 2000·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·H A Reinders-MesselinkW A Kamps
Jun 28, 2001·Leukemia & Lymphoma·K MatsubaraK Baba
Apr 22, 2004·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·J ClavelD Hémon
Oct 27, 2004·Neurophysiologie clinique = Clinical neurophysiology·Yann PéréonPierre Guihéneuc
Jan 3, 2006·Journal of the Neurological Sciences·Louis H Weimer, David Podwall
Dec 8, 2006·Revue neurologique·K Viala
Nov 17, 2009·Journal of the Peripheral Nervous System : JPNS·Sindhu RamchandrenJames G Gurney
Nov 26, 2009·Indian Journal of Pediatrics·Sunil GomberDevender Chhonker
May 28, 2010·Journal of Pediatric Hematology/oncology·Zarina Abdul LatiffRahman Jamal
Dec 14, 2011·European Journal of Pharmacology·Puneet KumarAnil Kumar
Jan 23, 2013·International Journal of Clinical Pharmacy·Serkan Feyyaz YalinMehmet Riza Altiparmak
Jun 20, 2013·Journal of Child Neurology·Puneet JainR M Pandey
Jul 5, 2013·Blood Research·Jae Min LeeJeong Ok Hah
Citations
Apr 28, 2016·Neurological Research·F Gokcem Yildiz, Çagrı Mesut Temucin
May 5, 2016·Journal of Applied Toxicology : JAT·Zhi-Bin TongDavid Gerhold
Sep 25, 2016·Cancer Treatment Reviews·Tejaswi KandulaMichelle A Farrar
Apr 5, 2017·Journal of Pediatric Hematology/oncology·Marko KavcicJanez Jazbec
Feb 1, 2017·Pediatric Blood & Cancer·Chee Geap TayChoong Yi Fong
Nov 5, 2019·Pediatric Hematology and Oncology·Nassr NamaShahrad Rod Rassekh
May 26, 2018·JAMA Neurology·Tejaswi KandulaSusanna B Park
Jun 20, 2019·Cancer Chemotherapy and Pharmacology·Marie Lindhard MadsenKaren Dybkær
May 30, 2020·Cancer Cell International·Bryce KeenanKara L Vine
Dec 8, 2020·Expert Opinion on Drug Metabolism & Toxicology·Eleonora PozziGuido Cavaletti
Jul 6, 2021·Cancer Treatment and Research Communications·Ellen M Lavoie SmithUNKNOWN Toxic Neuropathy Consortium of the Peripheral Nerve Society
Jul 25, 2021·Journal of Clinical Medicine·Stefano ProUmberto Raucci